Clinical Trial Update: A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial update on epigenetic priming in newly diagnosed acute myeloid leukemia; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: ACTIVE_NOT_RECRUITING